Doximity Misses Earnings Forecasts Amid Downgrades and Weak Growth Outlook
May 14, 2026, 12:31 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The significant analyst downgrades and lowered forecasts signal decreased investor confidence, matching historical examples of declining share prices following similar downgrades.
AI summary
What happened, with direct paths to the underlying reporting
Doximity's Q4 earnings missed expectations, prompting significant analyst downgrades and lower future revenue guidance. The stock is struggling at a new 52-week low, indicating ongoing challenges amidst soft advertising demand. Investors should be cautious as growth slows and sentiment weakens.
Doximity reported Q4 revenue of $145.4 million, beating estimates.
Q4 adjusted earnings missed projections at 26 cents per share.
The company expects FY 2027 revenue guidance below estimates.
DOCS trading at a 52-week low, down over 61% year-to-date.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Doximity reported Q1 results with an earnings miss but raised full-year revenue guidance, highlighting stronger AI-driven engagement. Analysts turned more bullish on improving gro…
Doximity delivered a mixed Q4 with soft full-year guidance as the HCP digital pharma ad market faces policy and macro headwinds. Management guides modest growth at or below 5% thi…
Doximity's upcoming earnings report on May 13 is expected to reveal weaker-than-last-year performance, with EPS projected to drop to $0.28. The resignation of CFO Anna Bryson rais…
Doximity reported Q3 revenue of $185.05 million, surpassing analyst estimates, with a year-over-year growth of 10%. This performance suggests positive momentum in their business m…